Current
Project goals
To investigate characteristics and outcomes of pregnancy in patients with atopic dermatitis. The central goal of the ADCARE Preg‑AD feasibility study is to test whether frequent, structured follow-up after high-risk pregnancies is feasible and effective—both in terms of patient engagement and early detection and management of cardiovascular risks. If successful, it would pave the way for larger trials and aims to shape new guidelines for postpartum care in women with pregnancy-related placental complications.
Project description
Preg AD is a feasibility trial focusing on women who experienced hypertensive pregnancy disorders (like preeclampsia, pregnancy-induced hypertension, or chronic hypertension) or intrauterine growth restriction (IUGR), collectively grouped as placental dysfunctions, which affect 5–10% of pregnancies.
Study 1: Physician Survey
- Global physician survey completed
- Manuscript in peer-review
Study 2: Patient Survey
- IRB approved
- Global recruitment: 14 active centers n=44 (02/2025)
Project duration
TBD
Location
50 active patients from many Centres
across Spain, Germany, Greece, Nepal and Turkey
Status
In progress
Project lead
Prof. Dr. Torsten Zuberbier
Dr. Katarina Stevanovic
Dr. Manuel Pereira
Steering committee
TBD
